Classification of Muscle Invasive Bladder Cancer to Predict Prognosis of Patients Treated with Immunotherapy

Table 1

Clinical characteristics of TME subtypes from TCGA-MIBC dataset. Abbreviations: TME: tumor microenvironment; MIBC: muscle invasive bladder cancer.

Characteristics	Subtype 1 (EC)	Subtype 2 (IC)	value
	Gender				0.881
Female	48 (27.3%)	57 (28.5%)
Male	128 (72.7%)	143 (71.5%)
Age (years)			0.006
20-50	19 (10.8%)	25 (12.5%)
50-70	67 (38.1%)	105 (52.5%)
70-90	90 (51.1%)	70 (35.0%)
Stage			<0.001
Stages I-II	40 (22.7%)	87 (43.5%)
Stages III-IV	136 (77.3%)	113 (56.5%)